KPIs. Following the Initial Period, GW commits to use commercially reasonable efforts to reach and consistently maintain a target of *** percent (***%) for the KPIs. In the event GW fails to meet a KPI with respect to a particular Firm Order, within thirty (30) days of such KPI failure GW shall (i) investigate the cause of such failure and (ii) report the results of the investigation to NOVARTIS in writing along with a plan of the actions to be taken by GW to prevent or minimize the likelihood of such cause contributing *** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. to a future failure to meet a KPI. At NOVARTIS’ request GW will discuss such a report and plan of action with NOVARTIS. Thereafter, GW will report to NOVARTIS on a regular basis its progress with implementing each plan of action.
Appears in 3 contracts
Sources: Manufacturing and Supply Agreement, Manufacturing and Supply Agreement (Gw Pharmaceuticals PLC), Manufacturing and Supply Agreement (Gw Pharmaceuticals PLC)